|
|
|
| home > white papers > Choosing the Right CMO for HPAPI Manufacturing - AMRI |
|
|
 WHITE PAPERS |
|
AMRI
|
|
Choosing the Right CMO for HPAPI Manufacturing
|
|
Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PHASTAR Launches Pro-Bono Scheme for Charities
New pro-bono scheme allows charities to access PHASTAR’s biometrics experts at no cost
More info >> |
|
 |
White Papers |
 |
|
Recommendations Sourcing Human Biospecimens
BioIVT
The foundations for protecting human research subjects come from the
ethical principles surrounding the Belmont report : Respect for persons,
beneficence, and justice. The use of human biospecimens in research
supports these principles with legal and ethical regulations - the most
important of which is permission.(1) This permission may come directly
from the donor or granted by others with authorization to protect the
interests of biospecimen donors.
More info >> |
|
|
|
